The purpose of these $85,000 pilot awards is to stimulate and support collaborative, innovative research on the potential role of microbes or pathogens in the development of Alzheimer’s disease (AD).
Successful applications will propose feasible projects or experiments to test specific hypotheses, generate strong preliminary data, or develop a critical resource to advance this field of inquiry. All types of research, from any point along the translational spectrum, are welcome. Topics of interest include, but are not limited to:
- Associations between specific pathogens or microbiomes and AD risk or pathology
- Advancement of new models to investigate the role of microbes or pathogens in AD
- Understanding the consequences of infections, antimicrobials, or vaccines on AD or markers of AD risk
Letters of intent are due by July 10, 2023.